MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Demographic feature and clinical characteristic of patients with Parkinson’s disease in Isfahan, Iran

    M. Salari (Isfahan, Islamic Republic of Iran)

    Objective: To evaluated demographic and clinical characteristic feature of patients with Parkinson's disease in Isfahan city in Iran. Background: Parkinson's disease (PD) is one of…
  • 2016 International Congress

    Application of the MDS research criteria for prodromal Parkinson’s disease to the longitudinal population-based Bruneck study cohort

    P. Mahlknecht, A. Gasperi, P. Willeit, S. Kiechl, H. Stockner, J. Willeit, G. Rungger, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To quantify the prevalence of prodromal phase of Parkinson's disease (PD) defined per 2015 MDS research criteria and their potential to predict incident clinically…
  • 2016 International Congress

    A novel interdisciplinary palliative care clinic for advanced Parkinson’s disease and Parkinsonian syndromes

    K.K. Tuck, L. Mann, S. Anderson, T. Borcich, J. Wilhelm, L. Bryans, J. Carter (Portland, OR, USA)

    Objective: We describe a novel interdisciplinary clinic for advanced Parkinson's disease (PD) and Parkinsonian syndromes incorporating palliative care principles to improve quality of life. Background:…
  • 2016 International Congress

    Assessment of malnutrition in patients with Parkinson’s disease

    O. Yilmaz Kusbeci, I. Inci, B. Donmez Colakoglu, N. Erdogmus Ince, R. Cakmur (Izmir, Turkey)

    Objective: We aimed to assess malnutrition and those at risk of malnutrition in PD patients with an age matched control group using the mini nutritional…
  • 2016 International Congress

    A validation study of a smartphone-based finger tapping application for quantitative assessment of bradykinesia in Parkinson’s disease

    C.Y. Lee, S.J. Kang, Y.E. Kim, U. Lee, H.I. Ma, Y.J. Kim (Anyang-si, Gyeonggi-do, Korea)

    Objective: We developed an application of smartphone tapper (SmpT) and sought to determine whether SmpT is applicable for clinical purpose by comparing SmpT parameters to…
  • 2016 International Congress

    A rare genetic transcriptomopathy syndrome involving TAF1 leading to insights into more common neurologic disorders, including X-linked dystonia-parkinsonism (XDP)

    G.J. Lyon (New York, NY, USA)

    Objective: We set out to discover the genetic basis of an X-linked genetic syndrome presenting with global developmental delay, intellectual disability, characteristic facial dysmorphology, generalized…
  • 2016 International Congress

    C9ORF72 intermediate repeat copies as a rare genetic cause of atypical Parkinsonian syndromes or Parkinson’s disease complicated by psychosis in a Sardinian population

    M. Meloni, A. Cannas, P. Solla, M.M. Mascia, G. Orofino, R. Farris, D. Ciaccio, E. Binaghi, M.R. Murru, F. Marrosu (Cagliari, Italy)

    Objective: To screen for the presence of C9ORF72 repeat expansions in patients affected by atypical parkinsonism syndromes and PD complicated by psychosis or dementia, and…
  • 2016 International Congress

    Clinical profile of Wilson’s disease at Yangon General Hospital, Myanmar

    S.M.M. Aye, K.M.P.P. Kyaw, Z. Myint Shwe, O. Ohnmar, Y.M. Aye, W.M. Thit (Yangon, Myanmar)

    Objective: To evaluate clinical, biochemical and imaging profile of patients with Wilson's Disease (WD). Background: There was no reported case series of WD in Myanmar.This…
  • 2016 International Congress

    Increased anti-MAG autoantibodies titers in Parkinson’s disease

    E. Papuc, K. Rejdak (Lublin, Poland)

    Objective: To search for biomarkers of neurodegenerative process in Parkinson's disease (PD).There is emerging evidence that humoral response may be involved in the pathogenesis and…
  • 2016 International Congress

    Hyperin inhibits lipopolysaccharide-induced microglia activation through p38 and NFκB signaling

    X. Zhang, Y.N. Wang, H.H. Fan, R. Yang, S.Y. Li, J.H. Zhu (Wenzhou, People's Republic of China)

    Objective: In this study, we aimed to investigate hyperin's potentiality in inhibition of neuroinflammation. Background: Hyperin is an active compound isolated from Rhododendron brachycarpum G.…
  • « Previous Page
  • 1
  • …
  • 420
  • 421
  • 422
  • 423
  • 424
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley